Share this postLong DNA for Difficult Applications: Dan Lin-Arlow, CEO, Ansa Biotech www.mendelspod.comCopy linkFacebookEmailNoteOtherMendelspod PodcastLong DNA for Difficult Applications: Dan Lin-Arlow, CEO, Ansa Biotech 8Share this postLong DNA for Difficult Applications: Dan Lin-Arlow, CEO, Ansa Biotech www.mendelspod.comCopy linkFacebookEmailNoteOther1×Preview0:00-8:12Audio playback is not supported on your browser. Please upgrade.Long DNA for Difficult Applications: Dan Lin-Arlow, CEO, Ansa Biotech Theral TimpsonSep 13, 2023∙ Paid8Share this postLong DNA for Difficult Applications: Dan Lin-Arlow, CEO, Ansa Biotech www.mendelspod.comCopy linkFacebookEmailNoteOtherShareChapters:0:00 World’s longest oligo8:45 Why is it difficult to synthesize long DNA?12:00 Proprietary TdT conjugate16:00 A billion-dollar market24:20 The computation model and its challenges28:35 More customers using generative AIMendelspod is now reader supported. Please consider upgrading to a paid subscription for the price of a couple cof…SubscribeThis post is for paid subscribersSubscribeAlready a paid subscriber? Sign inMendelspod PodcastOffering a front row seat to the Century of Biology, veteran podcast host Theral Timpson interviews the who's who in genomics and genomic medicine.Offering a front row seat to the Century of Biology, veteran podcast host Theral Timpson interviews the who's who in genomics and genomic medicine.SubscribeListen onSubstack AppRSS FeedAppears in episodeTheral TimpsonRecent EpisodesGeneticist Kevin Mitchell Attempts to Naturalize Free Will in New BookSep 12 • Theral TimpsonctDNA Testing Could Lead to New Ways of Staging Cancer Patients, Says Ben Weinberg, MedStar Georgetown Aug 27 • Theral Timpson14th Season Opener: Michael Levin on ‘The New Biology’ Aug 22 • Theral TimpsonThe Success of ctDNA Testing in Colorectal Cancer: Adham Jurdi, Natera Aug 20 • Theral TimpsonHenrik Zetterberg on the Current Excitement Around Alzheimer’s Research Aug 14 • Theral TimpsonThe Reboot of Consumer Genomics? with Kian Sadeghi, Nucleus GenomicsAug 6 • Theral TimpsonFrom Geospatial to Biospatial: Avi Veidman of Nucleai Jul 25 • Theral TimpsonNew Proteomics Technology Brings Unprecedented Sensitivity and Scale: Yuling Luo, CEO, Alamar Bio Jul 18 • Theral Timpson